The global extra corporeal membrane oxygenation (ECMO) system market is projected to record a CAGR of 4.74% during the forecast period, 2019-2028
The rising burden of chronic disorders, growing usage of ECMO technology, and technological advancements, are set to propel the growth of the market. MARKET INSIGHTS The ECMO is used for critically ill patients and neonates.
New York, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET FORECAST 2019-2028" - https://www.reportlinker.com/p05950037/?utm_source=GNW
It is popular for providing life support for longer durations.
The advent of new technologies is increasing the applications of ECMO technology.This includes enabling it for inter- and intra-hospital transport.
Short-term and long-term applications have undergone considerable technological advancements. Modern ECMO technology has improved biocompatibility and portability, and offers a simple and safe way of provision.
The CardioHelp System by Genitage AB is an EMCO system.Its features are compact, light-weight, and portability.
It supports both the heart and lungs.It is primarily used in the cases of respiratory and myocardial failure, and has a lifespan of almost 30 days.
Such advancements in technologies are projected to contribute to the growth of the market. However, the lack of specialized expertise and the expenses involved in the ECMO system, pose a hindrance to market growth.
REGIONAL INSIGHTS
The geographical segregation of the global extra corporeal membrane oxygenation (ECMO) system market includes the analysis of North America, Asia Pacific, Europe, and the rest of the world.North America is projected to dominate the global market by 2028.
The rising number of cardiovascular disease cases is attributed to the enhanced prospects of the market.
COMPETITIVE INSIGHTS
The companies are prioritizing innovation to sustain the competitive environment. Some of the leading companies in the market include, Elsius Biomedical Inc, Livanova Plc, Getinge AB, Alung Technologies Inc, Eurosets, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Companies mentioned
1. ABBOTT LABORATORIES
2. ALUNG TECHNOLOGIES INC
3. ELSIUS BIOMEDICAL INC
4. EUROSETS
5. GETINGE AB
6. LIVANOVA PLC
7. MEDTRONIC PLC
8. MICROPORT SCIENTIFIC CORPORATION
9. NIPRO CORPORATION
10. ORIGEN BIOMEDICAL INC
11. SPECTRUM MEDICAL
12. TERUMO MEDICAL CORPORATION
13. XENIOS AG (FRESENIUS SE & CO KGAA)
Read the full report: https://www.reportlinker.com/p05950037/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________